FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064155 [Registered on: 14/03/2024] Trial Registered Prospectively
Last Modified On: 12/03/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   : A clinical trial to study the effect of japapushpa formulation (asava kalpana) in management of mild iron deficiency anaemia  
Scientific Title of Study   A single arm interventional study to determine the effectiveness of japapushpa guda a novel formulation for mild iron deficiency anemia and rakta saaratha  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR NISHA BABU 
Designation  Professor and HOD of Dravyagunavijnanam 
Affiliation  Kerala university of health science 
Address  Sree Narayana institute of ayurvedic studies and research first floor room no.13 department of dravyaguna
Sreenarayana institute of ayurvedic studies and research Puthoor kollam
Kollam
KERALA
691513
India 
Phone  9656712927  
Fax    
Email  drnishaababu@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR NISHA BABU 
Designation  Professor and HOD of Dravyagunavijnanam 
Affiliation  Sree Narayana Institute of Ayurvedic science and research  
Address  Sree Narayana Health Care Society R Sankar Nagar Karimpinpuzha PO Pangode Puthur Kollam 691513 Kerala

Kollam
KERALA
691513
India 
Phone  9656712927  
Fax    
Email  drnishaababu@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Akarsha Sudhish 
Designation  Second professional BAMS junior student 
Affiliation  Kerala University Of Health Sciences 
Address  Kalavampara House, Valluvally, Koonammavu P.O,Eranakulam
Second professional BAMS junior student, Sree Narayana Institute of Ayurvedic Studies and Research, Puthoor, Kollam-691513 KERALA
Kollam
KERALA
683518
India 
Phone  9495787081  
Fax    
Email  akarshasudhish@gmail.com  
 
Source of Monetary or Material Support  
Sree Narayana Health Care Society R Sankar Nagar, Karimpinpuzha PO Pangode Puthur Kollam 691513 Kerala  
 
Primary Sponsor  
Name  Sree Narayana Health Care Society 
Address  Sree Narayana Health Care Society R Sankar Nagar, Karimpinpuzha PO Pangode Puthur Kollam 691513 Kerala  
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nisha Babu  Sree Narayana Institute of Ayurvedic Studies and Research Hospital  Department of Kaya chikitsa, Room number – 8, Sree Narayana Institute of Ayurvedic Studies and Research Hospital, Puthoor, Kollam-691513 KERALA
Kollam
KERALA 
9656712927

drnishaababu@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Sree Narayana Institute of Ayurvedic Studies and Research-institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:D509||Iron deficiency anemia, unspecified. Ayurveda Condition: PANDUROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugOther than Classical(1) Medicine Name: Japa pushpa guda, Reference: NA, Route: Oral, Dosage Form: Gudpak, Dose: 10(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 4 Weeks, anupAna/sahapAna: No, Additional Information: Japa pushpa guda is a new formulation. Properties of japa pushpa is mentioned in Ayurveda individually and properties of guda also. But the formulation is not explained.It is an anubhoota yoga, a formulation modified on basis of clinical efficacy by renowned Ayurvedic physicians
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  25.00 Year(s)
Gender  Both 
Details  Hb %9 g/dL - 12g/dL
students willing to participate in research 
 
ExclusionCriteria 
Details  Pregnancy
Lactation
Piles
Bleeding disorders like hemorrhage
diabetics 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
increase in amount of hemoglobin assessed through complete blood test after 8 weeks.   base line : assessment of amount of hemoglobin and inclusion into the study
4 weeks : repeat assessment of amount of hemoglobin
8 weeks : last assessment of amount of hemoglobin  
 
Secondary Outcome  
Outcome  TimePoints 
increase in rakta saarata score assessed through rakta saara assessment questionnaire   base line : rakta saarata score assessment before intervention
4 weeks: rakta saarata score after 4 weeks of intervention
8 weeks: rakta saarata score after 8 weeks of intervention  
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   25/03/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Open to Recruitment 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This study is an open labeled single  arm clinical trial. Study aims to determine the effect of daily consumption of japa pushpa guda for management of mild iron deficiency anemia and rakta saarata. The primary outcome measure will be the increase in amount of haemoglobin within 4 weeks of treatment.

 
Close